Amirreza Azimi

1.5k total citations
61 papers, 1.1k citations indexed

About

Amirreza Azimi is a scholar working on Pathology and Forensic Medicine, Neurology and Psychiatry and Mental health. According to data from OpenAlex, Amirreza Azimi has authored 61 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pathology and Forensic Medicine, 14 papers in Neurology and 10 papers in Psychiatry and Mental health. Recurrent topics in Amirreza Azimi's work include Multiple Sclerosis Research Studies (36 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (7 papers) and Systemic Sclerosis and Related Diseases (7 papers). Amirreza Azimi is often cited by papers focused on Multiple Sclerosis Research Studies (36 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (7 papers) and Systemic Sclerosis and Related Diseases (7 papers). Amirreza Azimi collaborates with scholars based in Iran, United States and United Kingdom. Amirreza Azimi's co-authors include Mohammad Ali Sahraian, Mohammad Khalili, Meisam Sanoobar, Mahsa Ghajarzadeh, Abdorreza Naser Moghadasi, Mehdi Mohammadifar, Shima Jazayeri, Mahmood Reza Gohari, Shahryar Eghtesadi and Ghazaleh Eskandari and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Vaccine.

In The Last Decade

Amirreza Azimi

60 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amirreza Azimi Iran 19 554 325 215 151 138 61 1.1k
Jesús Lovera United States 20 656 1.2× 241 0.7× 234 1.1× 168 1.1× 71 0.5× 33 1.2k
Rebecca Spain United States 23 817 1.5× 206 0.6× 335 1.6× 326 2.2× 84 0.6× 63 1.8k
Miguel Ángel Macías-Islas Mexico 20 597 1.1× 377 1.2× 182 0.8× 284 1.9× 48 0.3× 57 1.5k
Sarah Jesse Germany 18 153 0.3× 363 1.1× 490 2.3× 100 0.7× 31 0.2× 43 1.1k
Antonio Ibarra Mexico 25 1.1k 1.9× 394 1.2× 140 0.7× 124 0.8× 17 0.1× 103 2.0k
Mehrdokht Mazdeh Iran 20 259 0.5× 458 1.4× 104 0.5× 96 0.6× 13 0.1× 115 1.3k
Keren Regev Israel 22 326 0.6× 619 1.9× 234 1.1× 95 0.6× 7 0.1× 65 1.4k
Mark Stettner Germany 20 247 0.4× 331 1.0× 586 2.7× 72 0.5× 9 0.1× 68 1.5k
Cecília Rajda Hungary 20 374 0.7× 172 0.5× 95 0.4× 107 0.7× 14 0.1× 52 919
Antonio Bruno Italy 24 287 0.5× 684 2.1× 103 0.5× 78 0.5× 12 0.1× 83 1.8k

Countries citing papers authored by Amirreza Azimi

Since Specialization
Citations

This map shows the geographic impact of Amirreza Azimi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amirreza Azimi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amirreza Azimi more than expected).

Fields of papers citing papers by Amirreza Azimi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amirreza Azimi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amirreza Azimi. The network helps show where Amirreza Azimi may publish in the future.

Co-authorship network of co-authors of Amirreza Azimi

This figure shows the co-authorship network connecting the top 25 collaborators of Amirreza Azimi. A scholar is included among the top collaborators of Amirreza Azimi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amirreza Azimi. Amirreza Azimi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mohammadzadeh, Maryam, Kavous Firouznia, Farnam Mohebi, et al.. (2022). Does Gadolinium Deposition Lead to Metabolite Alteration in the Dentate Nucleus? An MRS Study in Patients with MS. American Journal of Neuroradiology. 43(10). 1403–1410. 1 indexed citations
3.
Azimi, Amirreza, et al.. (2022). Estimation the medical cost of multiple sclerosis in Iran; 2019–2020. BMC Health Services Research. 22(1). 137–137. 5 indexed citations
4.
Moghadasi, Abdorreza Naser, et al.. (2022). COVID-19 vaccine hesitancy in Iranian patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 60. 103723–103723. 8 indexed citations
5.
Doosti, Rozita, et al.. (2021). Neuromyelitis optica spectrum disorder (NMOSD) associated with cancer: A systematic review. Multiple Sclerosis and Related Disorders. 56. 103227–103227. 17 indexed citations
6.
Sahraian, Mohammad Ali, et al.. (2021). The study of COVID-19 infection following vaccination in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 57. 103363–103363. 5 indexed citations
7.
Sahraian, Mohammad Ali, et al.. (2021). Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV. Vaccine. 39(43). 6347–6350. 23 indexed citations
8.
Rafiee, Farnaz, Abdorreza Naser Moghadasi, Mohammad Ali Sahraian, et al.. (2020). Stressful life events, socioeconomic status, and the risk of neuromyelitis optica spectrum disorder: A population-based case-control study. Multiple Sclerosis and Related Disorders. 46. 102544–102544. 9 indexed citations
9.
Azadvari, Mohaddeseh, et al.. (2020). Bladder Dysfunction in Iranian Patients with Multiple Sclerosis. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Ghajarzadeh, Mahsa, et al.. (2020). Efficacy and safety of rituximab in treating patients with multiple sclerosis (MS): A systematic review and meta-analysis. Autoimmunity Reviews. 19(8). 102585–102585. 7 indexed citations
11.
Azadvari, Mohaddeseh, et al.. (2020). <p>Bladder Dysfunction in Iranian Patients with Multiple Sclerosis</p>. Journal of Multidisciplinary Healthcare. Volume 13. 345–349. 2 indexed citations
12.
Azimi, Amirreza, et al.. (2019). Effects of Vitamin D Supplements on IL-10 and INFγ Levels in Patients with Multiple Sclerosis: a Systematic Review and Meta-Analysis. MAEDICA – a Journal of Clinical Medicine. 14(4). 413–417. 5 indexed citations
13.
Azimi, Amirreza, Sara Hanaei, Mohammad Ali Sahraian, et al.. (2019). Incidence of seroconversion and sero-reversion in patients with multiple sclerosis (MS) who had been treated with natalizumab: A systematic review and meta-analysis. Journal of Clinical Neuroscience. 71. 129–134. 6 indexed citations
14.
Azimi, Amirreza, et al.. (2018). Impossible Differential Cryptanalysis of Reduced-Round Midori64 Block Cipher (Extended Version). 10(1). 3–13. 1 indexed citations
15.
Roostaei, Tina, Rahil Mashhadi, Rozita Doosti, et al.. (2018). Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis. Multiple Sclerosis Journal. 25(4). 532–540. 16 indexed citations
16.
Rezaeimanesh, Nasim, Soodeh Razeghi Jahromi, Zeinab Ghorbani, et al.. (2018). Various Types of Dietary Sugar and Neuromyelitis Optica Spectrum Disorder. Multiple Sclerosis and Related Disorders. 26. 244–244. 3 indexed citations
17.
Khalili, Mohammad, et al.. (2017). Effect of alpha-lipoic acid on asymmetric dimethylarginine and disability in multiple sclerosis patients: A randomized clinical trial. SHILAP Revista de lepidopterología. 9(7). 4899–4905. 17 indexed citations
18.
Azimi, Amirreza, et al.. (2017). Prevalence and predictors of dysphagia in Iranian patients with multiple sclerosis. Medical Journal of the Islamic Republic of Iran. 31(1). 882–885. 9 indexed citations
19.
Mohamadi, Amin, et al.. (2016). Personality characteristics in MS patients: The role of avoidant personality. Clinical Neurology and Neurosurgery. 144. 23–27. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jesús Lovera Breakdown of academic impact, for papers by Rebecca Spain Breakdown of academic impact, for papers by Miguel Ángel Macías-Islas Breakdown of academic impact, for papers by Sarah Jesse Breakdown of academic impact, for papers by Antonio Ibarra Breakdown of academic impact, for papers by Mehrdokht Mazdeh Breakdown of academic impact, for papers by Keren Regev Breakdown of academic impact, for papers by Mark Stettner Breakdown of academic impact, for papers by Cecília Rajda Breakdown of academic impact, for papers by Antonio Bruno
Rankless by CCL
2026